Ocugen Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +63.2% | -83.2% | +12.5% | -0.4% | -32.7% | +93.8% | -7.3% | +27.6% | -111.0% | – | -2.9% | – | |
| – | -97.5% | +0.0% | +4,873.2% | – | – | – | – | – | – | – | – | – | |
| – | – | -82.7% | +12.5% | -0.4% | -32.7% | +93.8% | -7.3% | +27.6% | -111.0% | – | -2.9% | – | |
| – | +34.8% | -28.2% | +30.4% | -8.9% | +2.2% | +14.9% | -11.8% | +32.7% | -4.3% | +5.5% | -5.0% | – | |
| – | -43.2% | +24.2% | +20.0% | -18.3% | +0.5% | +2.2% | +4.8% | +21.6% | -25.5% | +32.4% | -10.8% | – | |
| – | +61.4% | -9.7% | +25.4% | -13.3% | +1.5% | +9.4% | -5.1% | +27.7% | -13.3% | +15.3% | -7.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +15.8% | +24.2% | +1.3% | -0.8% | +239.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.